Search Results - "ARENDS, Joop E"

The Effect of Efavirenz on Reward Processing in Asymptomatic People Living with HIV: A Randomized Controlled Trial by Oomen, Patrick G A, Hakkers, Charlotte S, Arends, Joop E, van der Berk, Guido E L, Pas, Pascal, Hoepelman, Andy I M, van Welzen, Berend J, du Plessis, Stefan

“…Functional magnetic resonance imaging (fMRI) studies have demonstrated that HIV-infection affects the fronto-striatal network. It has not been examined what…”
Get more information

The balancing perspective of hard-to-reach hepatitis C patients who were lost to follow-up: A qualitative study by Kracht, Patricia A M, Arends, Joop E, Hoepelman, Andy I M, Vervoort, Sigrid C J M

“…In the foreseeable future, patients with hepatitis C virus (HCV) with good healthcare access will all have been cured and the lost to follow-up (LFU)…”
Get full text

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? by van Welzen, Berend J., Mudrikova, Tania, El Idrissi, Ayman, Hoepelman, Andy I. M., Arends, Joop E.

“…The burden of liver-related morbidity remains high among HIV-infected patients, despite advances in the treatment of HIV and viral hepatitis. Especially, the…”
Get full text

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa by Maponga, Tongai Gibson, Andersson, Monique I, van Rensburg, Christoffel J, Arends, Joop E, Taljaard, Jantjie, Preiser, Wolfgang, Glashoff, Richard H

“…Co-infection with HIV negatively impacts the progression of chronic hepatitis B virus (HBV) infection, including causing rapid progression to liver fibrosis…”
Get full text

Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis by Kracht, Patricia A. M, Arends, Joop E, Hoepelman, Andy I. M, Kretzschmar, Mirjam E. E

“…Abstract Background The hepatitis C virus (HCV) infection is a candidate disease for micro-elimination. Accurate baseline HCV prevalence estimation is…”
Get full text

HIV, HCV and HBV: A Review of Parallels and Differences by Leoni, Maria C., Ustianowski, Andrew, Farooq, Hamzah, Arends, Joop E.

“…Elimination of the three blood-borne viruses—human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV)—as public health issues may be…”
Get full text

Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection by Feuth, Thijs, Arends, Joop E, Fransen, Justin H, Nanlohy, Nening M, van Erpecum, Karel J, Siersema, Peter D, Hoepelman, Andy I M, van Baarle, Debbie

“…To investigate whether T-cell activation and exhaustion is linked to HCV- and HIV disease parameters in HIV/HCV infected individuals, we studied T-cell…”
Get full text

Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals by Popping, Stephanie, Cuypers, Lize, Claassen, Mark A. A, van den Berk, Guido E, De Weggheleire, Anja, Arends, Joop E, Boerekamps, Anne, Molenkamp, Richard, Koopmans, Marion P. G, Verbon, Annelies, Boucher, Charles A. B, Rijnders, Bart, van de Vijver, David A. M. C

“…Background: In the Netherlands, unrestricted access to direct-acting antivirals (DAAs) halved the incidence of acute hepatitis C virus (HCV) infections among…”
Get full text

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review by Arends, Joop E., Lieveld, Faydra I., Ahmad, Shazaad, Ustianowski, Andrew

“…Although current therapies can be successful at suppressing hepatitis B viral load, long-term viral cure is not within reach. Subsequent strategies combining…”
Get full text

Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial by Oomen, Patrick G. A., Hakkers, Charlotte S., Arends, Joop E., van der Berk, Guido E. L., Pas, Pascal, Hoepelman, Andy I. M., van Welzen, Berend J., du Plessis, Stefan

“…Introduction It is unclear whether neurotoxicity due to the antiretroviral drug efavirenz (EFV) results in neurocognitive impairment in people living with HIV…”
Get full text

Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case–Control Diagnostic Validation Study by Hage, Kris, van de Kerkhof, Marita, Boyd, Anders, Carson, Joanne M., Newsum, Astrid M., Matser, Amy, van der Valk, Marc, Brinkman, Kees, Arends, Joop E., Lauw, Fanny N., Rijnders, Bart J. A., van Eeden, Arne, Martinello, Marianne, Matthews, Gail V., Schinkel, Janke, Prins, Maria

“…We assessed the predictive capacity of the HCV-MOSAIC risk score, originally developed for primary early HCV infection, as a screening tool for HCV reinfection…”
Get full text

Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C by Isfordink, Cas J, Brakenhoff, Sylvia M, van Dijk, Marleen, van der Valk, Marc, de Knegt, Rob J, Arends, Joop E, Drenth, Joost PH

“…BackgroundThe Netherlands has a low hepatitis C virus (HCV) prevalence, estimated at 0.16%. Previous studies have shown that up to 30% of the diagnosed HCV…”
Get full text

Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study by Kracht, Patricia A M, de Gee, Elisabeth A, van der Poel, Agnes, Verhagen, Marc A M T, Hoepelman, Andy I M, Croes, Esther A, Arends, Joop E

“…People who inject drugs (PWID) are disproportionally affected by the hepatitis C virus (HCV) infection. In the Netherlands, active HCV transmission in PWID has…”
Get full text

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy by Boerekamps, Anne, van den Berk, Guido E, Lauw, Fanny N, Leyten, Eliane M, van Kasteren, Marjo E, van Eeden, Arne, Posthouwer, Dirk, Claassen, Mark A, Dofferhoff, Anton S, Verhagen, Dominique W M, Bierman, Wouter F, Lettinga, Kamilla D, Kroon, Frank P, Delsing, Corine E, Groeneveld, Paul H, Soetekouw, Robert, Peters, Edgar J, Hullegie, Sebastiaan J, Popping, Stephanie, van de Vijver, David A M C, Boucher, Charles A, Arends, Joop E, Rijnders, Bart J

“…Background Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infected patients. Modeling studies predict that universal HCV…”
Get full text

Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection by Lieveld, Faydra I, Swaans, Niels, Newsum, Astrid M, Ho, Cynthia K.Y, Schinkel, Janke, Molenkamp, Richard, van der Meer, Jan T.M, Arends, Joop E, Hoepelman, Andy I.M, Wensing, Anne M.J, Siersema, Peter D, Erpecum, Karel J. van, Boland, Greet J

“…AbstractBackground and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but…”
Get full text

Hepatitis B viral load and risk of HBV-related liver disease: from East to West? by Harkisoen, Soeradj, Arends, Joop E, van Erpecum, Karel J, van den Hoek, Anneke, Hoepelman, Andy I M

“…Chronic hepatitis B has a variable course in disease activity with a risk of clinical complications like liver cirrhosis and hepatocellular carcinoma. As…”
Get full text

Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: a longitudinal analysis by Newsum, Astrid M, Matser, Amy, Schinkel, Janke, van der Valk, Marc, Brinkman, Kees, van Eeden, Arne, Lauw, Fanny N, Rijnders, Bart J A, van de Laar, Thijs J W, van de Kerkhof, Marita, Smit, Colette, Boyd, Anders, Arends, Joop E, Prins, Maria

“…HIV-positive men who have sex with men (MSM) are at high risk of hepatitis C virus (HCV) reinfection following clearance of HCV, but risk factors specifically…”
Get full text

Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination by Dijk, Marleen, Drenth, Joost P.H., Arends, Joop E, Brakenhoff, Sylvia M, Isfordink, Cas J, de Knegt, Rob, Valk, Marc

“…Since the advent of direct‐acting antivirals, elimination of hepatitis C viral (HCV) infections seems within reach. However, studies on the HCV cascade of care…”
Get full text

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment by Smolders, Elise J., de Kanter, Clara T. M. M., van Hoek, Bart, Arends, Joop E., Drenth, Joost P. H., Burger, David M.

“…Hepatitis C virus (HCV)-infected patients often suffer from liver cirrhosis, which can be complicated by renal impairment. Therefore, in this review we…”
Get full text

Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands by Isfordink, Cas J., Smit, Colette, Boyd, Anders, de Regt, Marieke J.A., Rijnders, Bart J.A., van Crevel, Reinout, Ackens, Robin P., Reiss, Peter, Arends, Joop E., van der Valk, Marc

“…To describe hepatitis C virus (HCV)-viremia prevalence and barriers to direct-acting antiviral (DAA) treatment during unrestricted access to DAA in a…”
Get full text